Oral and injectable semaglutide both act on the same GLP-1 receptor pathway, but injectable versions are often associated with greater average weight loss due to more consistent dosing and higher bioavailability
Proper medical oversight during administration minimizes these risks
Ipamorelin: 100-300 mcg per injection CJC-1295 (no DAC / mod GRF 1-29): 100-300 mcg per injection Frequency: 1-3 injections daily, subcutaneous, ideally on an empty stomach or 90 minutes after the last meal and before sleep Cycle length: 12-24 weeks followed by a 4-to-8-week break to avoid GH receptor downregulation Injection site: Abdomen, approximately 1-2 inches from the navel, rotating sites each injection The pre-sleep injection is prioritized because it coincides with the largest endogenous GH pulse, which occurs roughly 60-90 minutes after sleep onset and is tied to slow-wave sleep [8]
It reduces complications such as weakness, numbness, or tingling sensations associated with nerve disorders and improves nerve function
What the Phase 3 doses tell us The Phase 3 maintenance doses of 4mg, 9mg, and 12mg represent a refinement of the Phase 2 protocol
The frequency depends on your individual needs